ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.

Ezra Y Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.